Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignancies-Reference-Cited by-同舟云学术

Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignancies

Published:2013-01-31 Issue:5 Volume:121 Page:849-857
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Di Bartolomeo Paolo¹,Santarone Stella¹,De Angelis Gottardo²,Picardi Alessandra²,Cudillo Laura²,Cerretti Raffaella²,Adorno Gaspare³,Angelini Stefano²,Andreani Marco⁴,De Felice Lidia⁵,Rapanotti Maria Cristina²,Sarmati Loredana⁶,Bavaro Pasqua¹,Papalinetti Gabriele¹,Di Nicola Marta⁷,Papola Franco⁸,Montanari Mauro⁹,Nagler Arnon¹⁰,Arcese William²

Affiliation:

1. Department of Hematology, Bone Marrow Transplant Center, Spirito Santo Hospital, Pescara, Italy;

2. Rome Transplant Network, Department of Hematology, Stem Cell Transplant Unit, Tor Vergata University, Rome, Italy;

3. Department of Immunohematology, Division of Blood Bank, Tor Vergata University, Rome, Italy;

4. Laboratory of Immunogenetics and Transplant Biology, IME Foundation, Policlinic of Tor Vergata, Rome, Italy;

5. Department of Molecular Medicine, Sapienza University, Rome, Italy;

6. Division of Clinical Infectious Diseases, Tor Vergata University, Rome, Italy;

7. Department of Biomedical Sciences, Laboratory of Biostatistics, University of Chieti, Chieti, Italy;

8. Tissue Typing Regional Center, San Salvatore Hospital, L'Aquila, Italy;

9. Department of Hematology, University Hospital, Ancona, Italy; and

10. Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel

Abstract

Key Points Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation. Haploidentical hematopoietic stem cell transplantation for hematologic malignancies.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/121/5/849/1369599/zh800513000849.pdf

Reference48 articles.

1. The World Marrow Donor Association: 20 years of international collaboration for the support of unrelated donor and cord blood hematopoietic cell transplantation.;Petersdorf;Bone Marrow Transplant,2010

2. Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports.;Foeken;Bone Marrow Transplant,2010

3. Bone Marrow Donors Worldwide Statistics: Stem cell donor registries. Accessed June 30, 2012 http://www.bmdw.org

4. The great debate: haploidentical or cord blood transplant.;Ballen;Bone Marrow Transplant,2011

5. Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant.;Ballen;Blood,2012

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party;Bone Marrow Transplantation;2023-12-02

2. Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study;Frontiers in Immunology;2023-10-26

3. Comparison of Different Rabbit Anti-Thymocyte Globulin Formulations in the Prophylaxis of Graft-Versus-Host Disease: A Systematic Review;Journal of Clinical Medicine;2023-08-22

4. Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia;Frontiers in Immunology;2022-11-15

5. Haploidentical transplants with a G-CSF/ATG-based protocol: Experience from China;Blood Reviews;2022-11